AVLAYAH™ Permanent J-code: J1757

The Centers for Medicare & Medicaid Services (CMS) has assigned AVLAYAH™(tividenofusp alfa-eknm) the permanent Healthcare Common Procedure Coding System (HCPCS) J-code J1757, effective for dates of service on or after October 1, 2026.

HCPCS J-code: J1757
Description: Injection, tividenofusp alfa-eknm, 1 mg
NDC (10-digit): 84976-001-01
NDC (11-digit): 84976-0001-01

Correct coding and the completion of all forms are the responsibility of the provider submitting the claim for the item or service. Denali Therapeutics does not make any representation or guarantee concerning reimbursement or coverage for any item or service.

Reference:

  1. Centers for Medicare & Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) application summaries and coding determinations. Centers for Medicare & Medicaid Services. Accessed Aug 24, 2026. https://www.cms.gov/files/document/2026-hcpcs-application-summary-quarter-2-2026-drugs-biologicals.pdf

All rights reserved. AVLAYAH is a trademark of Denali Therapeutics. Denali and the Denali logo are registered trademarks of Denali Therapeutics.